Delivery Order SPE2DB22D3010-SPE2DB26FP0QY
- Not listed
- The Defense Logistics Agency awarded a $2,765.20 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. The contract represents a firm fixed price delivery order with no set-aside designation, reflecting competitive award terms. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility by September 17, 2025. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packages, with a contract ceiling value of $1,262.22. This firm fixed price delivery order is expected to be completed by September 12, 2025, and represents a non-set-aside, competitively awarded transaction. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams, with a ceiling value of $1,235.12. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams, with a ceiling value of $2,219.70 and a firm fixed price structure. This delivery order, which represents the ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls...
- The Defense Logistics Agency awarded a $1,646.92 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $1,518.22 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a non-set-aside competitive award with an ultimate completion date of May 13, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency has awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for testosterone 1% (25mg/2.5g) in 2.5-gram packets. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,520.52 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages to be delivered to the company's facility in Conshohocken, Pennsylvania. This firm fixed-price delivery order, designated as a non-competitive award, has an ultimate completion date of September 15, 2025. The order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Testosterone 50 mg/5 gram packets (unit dose, 5 grams) with a ceiling value of $1,010.68. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB26FP0QYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,036.80 to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by October 16, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies a broad portfolio of medications and medical supplies to federal healthcare systems, particularly supporting the Defense Health Agency and U.S. Coast Guard through DLA's Medical Supply Chain. The company was selected competitively for this delivery order based on its established capability to meet federal procurement requirements and its role as a primary vendor for pharmaceutical products across multiple therapeutic domains. This transaction represents a routine pharmaceutical replenishment supporting military medical operations through DLA's established procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/15/25 |